IRIS

Sfoglia per Rivista  ONCOLOGY REPORTS

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 7 a 17 di 17
Titolo Data di pubblicazione Autore(i) File
High mobility group A1 expression correlates with the histological grade of human glial tumors 1-gen-2004 Donato, G; MARTINEZ HOYOS, J; Amorosi, A; Maltese, L; Signorelli, F; Pentimalli, F; Pallante, P; Ferraro, G; Tucci, L; Signorelli, Cd; Fusco, A; Lavano, A; Viglietto, G; Volpentesta, G
High mobility group A1 expression correlates with the histological grade of human glial tumors. Oncology reports 11: 0-00, 2004 1-gen-2004 Donato, G; Martinez Hoyos, J; Amorosi, A; Maltese, L; Lavano, A; Volpentesta, G; Signorelli, F; Pentimalli, F; Pallante, P; Ferraro, G; Tucci, L; Signorelli, Cd; Viglietto, G; Fusco, A
Histone deacetylase inhibitors controls transcription and alternative splicing of prohibitin in thyroid tumor cells 1-gen-2011 Puppin, C; Passon, N; Franzoni, A; Russo, D.; Damante, G
Maintenance therapy with recombinant interferon alpha-2B (alpha IFN) in prognostically unfavourable aggressive non-Hodgkin's lymphomas (NHL) 1-gen-1996 Palmieri, G; Morabito, A; Rea, A; Lauria, R; Montesarchio, V; Biondi, E; Caraglia, M; Tagliaferri, P; Bianco, Ar
Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo 1-gen-2006 Quaresima, B; Faniello, C; Baudi, F; Crugliano, T; DI SANZO, M; Cuda, G; Costanzo, F; Venuta, S
MITOXANTRONE, ETOPOSIDE AND BLEOMYCIN (MEB) CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA PATIENTS NON-ELEGIBLE FOR STANDARD CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) COMBINATION 1-gen-1995 Tagliaferri, P; Matano, E; Rea, A; Famiani, M; Ciardiello, F; Tortora, G; Montesarchio, V; Morabito, A; Caraglia, M; Delaurentiis, M; Deplacido, S; Palmieri, G; Bianco, Ar
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade 1-gen-2010 Barresi, Valeria; Ieni, Antonio; Bolignano, Davide; Magno, Carlo; Buemi, Michele; Barresi, Gaetano
Phenotype characterization of human melanoma cells resistant to dabrafenib 1-gen-2017 Cordaro, Fg; De Presbiteris, Al; Camerlingo, R; Mozzilo, N; Pirozzi, G; Cavalcanti, E; Manca, A; Palmieri, G; Cosu, A; Ciliberto, G; Ascierto, Pa; Travali, S; Patriarca, Ej; Caputo, E
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: A systematic review and meta-analysis of randomized controlled trials 1-gen-2012 Ciliberto, D; Prati, U; Roveda, L; Barbieri, V; Staropoli, N; Abbruzzese, A; Caraglia, M; Di Maio, M; Flotta, D; Tassone, P; Tagliaferri, P
Sunitinib inhibits the tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors 1-gen-2011 Voce, P; Dagostino, M; Moretti, S; Sponziello, M; Rhoden, Kj; Calcinaro, F; Tallini, G; Puxeddu, E; Filetti, S; Russo, D.; Durante, C
The receptor super-antagonist Sant7: a potent and safe inhibitor of IL-6 on human myeloma cells 1-gen-1997 Savino, R; Demartis, A.; Ciapponi, L.; Sporeno, E.; Toniatti, C.; Bernassola, F.; Melino, G.; Klein, B.; Ciliberto, G
Mostrati risultati da 7 a 17 di 17
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile